Hu Zhe, Meng Jinlan, Cai Hongbing, Ma Na, Gao Xiujie, Li Xiaojuan, Xu Yan
Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University Guangzhou 510315, Guangdong, China.
Department of Physiology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University Guangzhou 510006, Guangdong, China.
Am J Cancer Res. 2022 Nov 15;12(11):5226-5240. eCollection 2022.
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor prevalent in southern China and Southeast Asia. Previous studies have shown that Kinesin Family Member 3A (KIF3A) plays a critical role in the oncogenesis of various cancer types. However, the role of KIF3A in NPC tumorigenesis and the mechanism underlying its function have not been reported. In this study, we found that KIF3A was significantly downregulated in NPC cells and tissues, and KIF3A expression in NPC patients was associated with tumor stage and was positively corrected with overall survival. In vitro and in vivo experiments indicated that overexpression of KIF3A inhibited NPC cell proliferation, migration, and invasion. Mechanistic studies found that KIF3A bound β-catenin and attenuated β-catenin aggregation in the nucleus. Moreover, rescue experiments demonstrated that the inhibitory effect of KIF3A on NPC proliferation, migration and invasion was partially dependent on β-catenin. Taken together, our data suggest that KIF3A interacts with β-catenin and attenuates NPC proliferation, migration, and invasion by suppressing the intranuclear aggregation of β-catenin. KIF3A may be a promising therapeutic target of patients with NPC.
鼻咽癌(NPC)是一种在中国南方和东南亚地区高发的恶性上皮性肿瘤。既往研究表明,驱动蛋白家族成员3A(KIF3A)在多种癌症类型的肿瘤发生过程中发挥关键作用。然而,KIF3A在鼻咽癌发生中的作用及其功能的潜在机制尚未见报道。在本研究中,我们发现KIF3A在鼻咽癌细胞和组织中显著下调,且鼻咽癌患者中KIF3A的表达与肿瘤分期相关,并与总生存期呈正相关。体外和体内实验表明,KIF3A过表达抑制鼻咽癌细胞的增殖、迁移和侵袭。机制研究发现,KIF3A与β-连环蛋白结合并减弱β-连环蛋白在细胞核内的聚集。此外,挽救实验表明,KIF3A对鼻咽癌增殖、迁移和侵袭的抑制作用部分依赖于β-连环蛋白。综上所述,我们的数据表明,KIF3A与β-连环蛋白相互作用,并通过抑制β-连环蛋白在细胞核内的聚集来减弱鼻咽癌的增殖、迁移和侵袭。KIF3A可能是鼻咽癌患者有前景的治疗靶点。